Historical shareholding details of iShares Russell 2000 ETF holdings in Apogee Therapeutics Inc. (APGE)

Monthly changes of iShares Russell 2000 ETF shareholding in Apogee Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Russell 2000 Etf 981,040 1.69%
Feb 27, 2025 Ishares Russell 2000 Etf 992,574 1.71%
Feb 26, 2025 Ishares Russell 2000 Etf 993,206 1.75%
Jan 31, 2025 Ishares Russell 2000 Etf 1,032,152 1.81%
Jan 29, 2025 Ishares Russell 2000 Etf 1,034,507 1.82%
Dec 31, 2024 Ishares Russell 2000 Etf 1,021,319 1.79%
Dec 30, 2024 Ishares Russell 2000 Etf 1,025,244 1.80%
Nov 30, 2024 Ishares Russell 2000 Etf 1,059,784 1.86%
Nov 27, 2024 Ishares Russell 2000 Etf 1,051,463 1.85%
Oct 31, 2024 Ishares Russell 2000 Etf 977,045 1.72%
Oct 30, 2024 Ishares Russell 2000 Etf 979,243 1.73%
Oct 29, 2024 Ishares Russell 2000 Etf 979,871 1.73%
Sep 30, 2024 Ishares Russell 2000 Etf 987,721 1.74%
Sep 27, 2024 Ishares Russell 2000 Etf 987,721 1.74%
Sep 25, 2024 Ishares Russell 2000 Etf 978,615 1.73%
Aug 30, 2024 Ishares Russell 2000 Etf 979,877 1.73%
Aug 29, 2024 Ishares Russell 2000 Etf 973,686 1.72%
Aug 28, 2024 Ishares Russell 2000 Etf 963,569 1.70%
Jul 31, 2024 Ishares Russell 2000 Etf 997,159 1.76%
Jul 29, 2024 Ishares Russell 2000 Etf 987,495 1.75%
Jun 28, 2024 Ishares Russell 2000 Etf 885,164 1.57%
Jun 13, 2024 Ishares Russell 2000 Etf 975,753 1.73%
May 29, 2024 Ishares Russell 2000 Etf 940,657 1.67%
Apr 26, 2024 Ishares Russell 2000 Etf 970,341 1.72%
Mar 28, 2024 Ishares Russell 2000 Etf 1,014,544 1.80%
Mar 27, 2024 Ishares Russell 2000 Etf 1,009,997 1.79%
Feb 29, 2024 Ishares Russell 2000 Etf 499,640 0.99%
Feb 02, 2024 Ishares Russell 2000 Etf 504,150 1.00%
Feb 01, 2024 Ishares Russell 2000 Etf 507,184 1.06%
Jan 29, 2024 Ishares Russell 2000 Etf 520,304 1.08%
Dec 27, 2023 Ishares Russell 2000 Etf 545,478 1.14%
Nov 29, 2023 Ishares Russell 2000 Etf 466,980 0.97%
Oct 27, 2023 Ishares Russell 2000 Etf 448,650 0.89%
Sep 27, 2023 Ishares Russell 2000 Etf 439,489 0.87%

View all ownership details of Apogee Therapeutics Inc.